Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
October 1, 2025
Evidence of an activity-enhancing conformational shift in Arabidopsis thaliana plant cysteine oxidase 4 induced by binding of substrate or substrate-mimics
Rebecca Latter, Jordi C J Hintzen, Laila M N Shah, et al.
Journal of Medicinal Chemistry
|
May 14, 1993
Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists
R N Misra, B R Brown, P M Sher, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 19, 2008
Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2
Bruce A Ellsworth, Wei Meng, Manorama Patel, et al.
Clinical Genetics
|
December 23, 2016
Genetic heterogeneity in Pakistani microcephaly families revisited
I Ahmad, S M Baig, A R Abdulkareem, et al.
Journal of Medicinal Chemistry
|
June 22, 2017
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT<sub>2C</sub> Receptor Agonists
Joseph Carpenter, Ying Wang, Gang Wu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2007
Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations
W N Washburn, T W Harper, G Wu, et al.
Journal of Medicinal Chemistry
|
February 12, 2008
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
Wei Meng, Bruce A Ellsworth, Alexandra A Nirschl, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor
A V Gavai, P M Sher, A B Mikkilineni, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 5, 2004
BMS-201620: a selective beta 3 agonist
W N Washburn, C-Q Sun, G Bisacchi, et al.
Journal of Medicinal Chemistry
|
November 5, 2013
Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic properties
Bruce A Ellsworth, Philip M Sher, Ximao Wu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
October 1, 2025
Evidence of an activity-enhancing conformational shift in Arabidopsis thaliana plant cysteine oxidase 4 induced by binding of substrate or substrate-mimics
Rebecca Latter, Jordi C J Hintzen, Laila M N Shah, et al.
Journal of Medicinal Chemistry
|
May 14, 1993
Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists
R N Misra, B R Brown, P M Sher, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 19, 2008
Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2
Bruce A Ellsworth, Wei Meng, Manorama Patel, et al.
Clinical Genetics
|
December 23, 2016
Genetic heterogeneity in Pakistani microcephaly families revisited
I Ahmad, S M Baig, A R Abdulkareem, et al.
Journal of Medicinal Chemistry
|
June 22, 2017
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT<sub>2C</sub> Receptor Agonists
Joseph Carpenter, Ying Wang, Gang Wu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2007
Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations
W N Washburn, T W Harper, G Wu, et al.
Journal of Medicinal Chemistry
|
February 12, 2008
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
Wei Meng, Bruce A Ellsworth, Alexandra A Nirschl, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor
A V Gavai, P M Sher, A B Mikkilineni, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 5, 2004
BMS-201620: a selective beta 3 agonist
W N Washburn, C-Q Sun, G Bisacchi, et al.
Journal of Medicinal Chemistry
|
November 5, 2013
Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic properties
Bruce A Ellsworth, Philip M Sher, Ximao Wu, et al.
Page
of 7